Top Medical Stocks Worth Watching - July 25th

Key Points

• Seven medical stocks including UnitedHealth Group, Hims & Hers Health, and Thermo Fisher Scientific are noted as key players based on their recent trading volume.
• UnitedHealth Group shares rose to $282.48 with a market cap of $256.25 billion, reflecting a 12-month trading range between $248.88 and $630.73.
• Hims & Hers Health experienced a significant stock increase to $57.70, with a market capitalization of $12.91 billion and a one-year high of $72.98.
• Walmart shares reached $97.48, along with a market cap of $777.89 billion, having traded over 7 million shares on the same day.

UnitedHealth Group, Hims & Hers Health, Thermo Fisher Scientific, Centene, Eli Lilly and Company, Elevance Health, and Walmart are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies operating in the healthcare sector, including pharmaceutical manufacturers, biotechnology firms, medical device makers and healthcare service providers. Their market performance is influenced by factors such as clinical trial results, regulatory approvals, changes in health policy and broader trends in patient care and medical research. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Shares of UnitedHealth Group stock traded up $3.90 during trading on Friday, hitting $282.48. 10,648,241 shares of the stock were exchanged, compared to its average volume of 11,316,131. UnitedHealth Group has a 12-month low of $248.88 and a 12-month high of $630.73. The stock has a market cap of $256.25 billion, a price-to-earnings ratio of 11.85, a price-to-earnings-growth ratio of 1.45 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The firm's 50-day moving average price is $301.79 and its 200 day moving average price is $427.21.

Read Our Latest Research Report on UNH

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

HIMS traded up $0.38 on Friday, reaching $57.70. The company had a trading volume of 39,261,374 shares, compared to its average volume of 33,727,785. Hims & Hers Health has a 1 year low of $13.47 and a 1 year high of $72.98. The stock has a market capitalization of $12.91 billion, a PE ratio of 83.55, a P/E/G ratio of 2.14 and a beta of 2.02. The stock has a 50-day moving average price of $53.29 and a 200-day moving average price of $42.56.

Read Our Latest Research Report on HIMS

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

TMO traded up $2.35 on Friday, reaching $477.38. The company had a trading volume of 2,931,045 shares, compared to its average volume of 2,503,097. The company has a quick ratio of 1.38, a current ratio of 1.93 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $180.21 billion, a PE ratio of 27.64, a P/E/G ratio of 2.25 and a beta of 0.77. Thermo Fisher Scientific has a 1 year low of $385.46 and a 1 year high of $627.88. The stock has a 50-day moving average price of $412.43 and a 200-day moving average price of $470.68.

Read Our Latest Research Report on TMO

Centene (CNC)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

NYSE CNC traded up $1.64 during trading on Friday, reaching $28.40. The company's stock had a trading volume of 49,215,497 shares, compared to its average volume of 7,572,986. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a market cap of $14.13 billion, a price-to-earnings ratio of 4.22, a P/E/G ratio of 0.55 and a beta of 0.44. Centene has a twelve month low of $26.25 and a twelve month high of $80.59. The business's fifty day moving average price is $47.43 and its 200-day moving average price is $56.11.

Read Our Latest Research Report on CNC

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE LLY traded up $3.49 during trading on Friday, reaching $808.92. The company's stock had a trading volume of 1,616,244 shares, compared to its average volume of 3,757,608. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.06 and a current ratio of 1.37. The firm has a market cap of $766.65 billion, a price-to-earnings ratio of 65.80, a P/E/G ratio of 1.16 and a beta of 0.40. Eli Lilly and Company has a twelve month low of $677.09 and a twelve month high of $972.53. The business's fifty day moving average price is $770.86 and its 200-day moving average price is $800.14.

Read Our Latest Research Report on LLY

Elevance Health (ELV)

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

NYSE ELV traded up $10.06 during trading on Friday, reaching $290.49. The company's stock had a trading volume of 2,899,797 shares, compared to its average volume of 1,894,582. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.44 and a current ratio of 1.44. The firm has a market cap of $65.41 billion, a price-to-earnings ratio of 12.40, a P/E/G ratio of 1.09 and a beta of 0.60. Elevance Health has a twelve month low of $274.40 and a twelve month high of $567.26. The business's fifty day moving average price is $363.07 and its 200-day moving average price is $393.21.

Read Our Latest Research Report on ELV

Walmart (WMT)

Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications.

Shares of Walmart stock traded up $0.88 on Friday, reaching $97.48. 7,890,283 shares of the stock were exchanged, compared to its average volume of 19,288,119. The firm has a market capitalization of $777.89 billion, a PE ratio of 41.65, a PEG ratio of 4.60 and a beta of 0.68. Walmart has a 1-year low of $66.67 and a 1-year high of $105.30. The business has a fifty day moving average price of $96.77 and a two-hundred day moving average price of $94.77. The company has a current ratio of 0.78, a quick ratio of 0.22 and a debt-to-equity ratio of 0.47.

Read Our Latest Research Report on WMT

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.